Filing Details

Accession Number:
0001516551-24-000116
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-19 21:20:46
Reporting Period:
2024-11-15
Accepted Time:
2024-11-19 21:20:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1516551 Skye Bioscience Inc. SKYE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1425052 Punit Dhillon 11250 El Camino Real, Suite 100
C/O Skye Bioscience, Inc.
San Diego CA 92130
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-11-15 364 $5.55 412,369 No 4 S Direct
Common Stock Disposition 2024-11-18 82,546 $4.99 329,823 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 9,343 Indirect Trust
Footnotes
  1. The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of performance-based restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary transactions by the Reporting Person.
  2. The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $4.98 to $5.08, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.
  3. Shares held by a family trust of which the reporting person is the trustee.